Artiva Biotherapeutics, Inc. ARTV Other accounts receivable (net of allowances of $37 in 2026 and $37 in 2025)
Other accounts receivable (net of allowances of $37 in 2026 and $37 in 2025) at other companies
Other financials
Where this comes from
Reported directly by Artiva Biotherapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherReceivablesNetCurrent.
The official record: Artiva Biotherapeutics, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Artiva Biotherapeutics, Inc.'s other accounts receivable (net of allowances of $37 in 2026 and $37 in 2025).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Artiva Biotherapeutics, Inc.'s other accounts receivable (net of allowances of $37 in 2026 and $37 in 2025)?
- Artiva Biotherapeutics, Inc. (ARTV) reported other accounts receivable (net of allowances of $37 in 2026 and $37 in 2025) of $67K in Q4 2025.
- How has Artiva Biotherapeutics, Inc.'s other accounts receivable (net of allowances of $37 in 2026 and $37 in 2025) changed year-over-year?
- Artiva Biotherapeutics, Inc.'s other accounts receivable (net of allowances of $37 in 2026 and $37 in 2025) decreased by 54.1% year-over-year, from $146K to $67K.
- What is the long-term trend for Artiva Biotherapeutics, Inc.'s other accounts receivable (net of allowances of $37 in 2026 and $37 in 2025)?
- Over 2 years (2023 to 2025), Artiva Biotherapeutics, Inc.'s other accounts receivable (net of allowances of $37 in 2026 and $37 in 2025) has grown at a -69.6% compound annual growth rate (CAGR), from $724K to $67K.